Compass Pathways Plc ADR (CMPS)

전일 마감가:

$7.99

열려 있는:

$8.01

하루 거래량:

335.89K

시가총액:

$536.11M

수익:

-

순이익/손실:

$-118.46M

주가수익비율:

-3.3362

EPS:

-2.35

순현금흐름:

$-97.44M

1주 성능:

-0.25%

1개월 성능:

-8.09%

6개월 성능:

+30.45%

1년 성능:

-7.76%

1일 변동 폭

$7.71

$8.1899

52주 변동 폭

$5.01

$12.75

Compass Pathways Plc ADR Stock (CMPS) Company Profile

명칭

Compass Pathways Plc ADR

부문

Healthcare (1209)

산업

Medical Care Facilities (59)

전화

44 64 6905 3974

주소

1 Ashley Road, 3rd Floor, Altrincham

직원

0

트위터

다음 수익 날짜

2024-05-08

최신 SEC 제출 서류

CMPS's Discussions on Twitter

Compass Pathways Plc ADR Stock (CMPS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-12	개시	Deutsche Bank	Buy
2022-11-21	재개	Berenberg	Buy
2022-11-01	개시	Loop Capital	Buy
2021-10-29	개시	Oppenheimer	Outperform
2021-07-13	개시	Citigroup	Buy
2021-06-28	개시	Maxim Group	Buy
2021-05-11	개시	Cantor Fitzgerald	Overweight
2021-04-01	개시	ROTH Capital	Buy
2020-10-14	개시	H.C. Wainwright	Buy
2020-10-13	개시	Berenberg	Buy
2020-10-13	개시	Canaccord Genuity	Buy
2020-10-13	개시	Cowen	Outperform
2020-10-13	개시	Evercore ISI	Outperform

모두보기

Compass Pathways Plc ADR 주식(CMPS)의 최신 뉴스

Earnings call: COMPASS Pathways reports progress on COMP360 treatment - Investing.com

Investing.com

COMPASS Pathways PLC Sponsored ADR (CMPS) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo News UK

Yahoo News UK

Investor's Toolkit: Key Ratios for Assessing Compass Pathways Plc ADR (CMPS)'s Performance – DWinneX - The Dwinnex

The Dwinnex

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

The Motley Fool

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire Inc.

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

GlobeNewswire Inc.

Compass Pathways Plc ADR (CMPS) 재무 분석

Compass Pathways Plc ADR (CMPS) 순이익 2024

Compass Pathways Plc ADR (CMPS) 현금흐름 2024

Compass Pathways Plc ADR (CMPS) 주당 순이익 2024